142 related articles for article (PubMed ID: 24469564)
41. The emergence of Ph-, trisomy -8+ cells in patients with chronic myeloid leukemia treated with imatinib mesylate.
Feldman E; Najfeld V; Schuster M; Roboz G; Chadburn A; Silver RT
Exp Hematol; 2003 Aug; 31(8):702-7. PubMed ID: 12901975
[TBL] [Abstract][Full Text] [Related]
42. Targeted drugs in chronic myeloid leukemia.
Gora-Tybor J; Robak T
Curr Med Chem; 2008; 15(29):3036-51. PubMed ID: 19075651
[TBL] [Abstract][Full Text] [Related]
43. Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience.
Braziel RM; Launder TM; Druker BJ; Olson SB; Magenis RE; Mauro MJ; Sawyers CL; Paquette RL; O'Dwyer ME
Blood; 2002 Jul; 100(2):435-41. PubMed ID: 12091333
[TBL] [Abstract][Full Text] [Related]
44. Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.
O'Dwyer ME; Gatter KM; Loriaux M; Druker BJ; Olson SB; Magenis RE; Lawce H; Mauro MJ; Maziarz RT; Braziel RM
Leukemia; 2003 Mar; 17(3):481-7. PubMed ID: 12646934
[TBL] [Abstract][Full Text] [Related]
45. Acute lymphoblastic leukemia without the Philadelphia chromosome occurring in chronic myelogenous leukemia with the Philadelphia chromosome.
Jin Huh H; Won Huh J; Myong Seong C; Lee M; Soon Chung W
Am J Hematol; 2003 Nov; 74(3):218-20. PubMed ID: 14587058
[TBL] [Abstract][Full Text] [Related]
46. [Efficacy of imatinib mesylate, a specific inhibitor of BCR/ABL tyrosine kinase, on chronic myeloid leukemia in blast phase].
Zhang GC; Zheng D; Li QH; Li XH; Cai CC; Luo SK; Li J; Peng AH; Tong XZ; Tan EX; Hong WD
Ai Zheng; 2004 Dec; 23(12):1696-9. PubMed ID: 15601563
[TBL] [Abstract][Full Text] [Related]
47. Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis.
Marzocchi G; Castagnetti F; Luatti S; Baldazzi C; Stacchini M; Gugliotta G; Amabile M; Specchia G; Sessarego M; Giussani U; Valori L; Discepoli G; Montaldi A; Santoro A; Bonaldi L; Giudici G; Cianciulli AM; Giacobbi F; Palandri F; Pane F; Saglio G; Martinelli G; Baccarani M; Rosti G; Testoni N;
Blood; 2011 Jun; 117(25):6793-800. PubMed ID: 21447834
[TBL] [Abstract][Full Text] [Related]
48. Megakaryocytic blast crisis at presentation in a pediatric patient with chronic myeloid leukemia.
Al-Shehri A; Al-Seraihy A; Owaidah TM; Belgaumi AF
Hematol Oncol Stem Cell Ther; 2010; 3(1):42-6. PubMed ID: 20231813
[TBL] [Abstract][Full Text] [Related]
49. Sustained durability of responses and improved progression-free and overall survival with imatinib treatment for accelerated phase and blast crisis chronic myeloid leukemia: long-term follow-up of the STI571 0102 and 0109 trials.
Silver RT; Cortes J; Waltzman R; Mone M; Kantarjian H
Haematologica; 2009 May; 94(5):743-4. PubMed ID: 19407320
[No Abstract] [Full Text] [Related]
50. Chromosomal abnormalities in Ph- cells of patients on imatinib.
McMullin MF; Humphreys M; Byrne J; Russell NH; Cuthbert RJ; O'Dwyer ME
Blood; 2003 Oct; 102(7):2700-1; author reply 2701. PubMed ID: 14504073
[No Abstract] [Full Text] [Related]
51. Morphological effects of imatinib mesylate (STI571) on the bone marrow and blood of patients with Philadelphia chromosome (Ph) positive chronic myeloid leukaemia.
McNamara C; Grigg A; Szer J; Roberts A; Campbell L; Hoyt R; Lynch K; Juneja S
Clin Lab Haematol; 2003 Apr; 25(2):119-25. PubMed ID: 12641616
[TBL] [Abstract][Full Text] [Related]
52. Imatinib mesylate in the treatment of chronic myelogenous leukemia.
Borthakur G; Cortes JE
Int J Hematol; 2004 Jun; 79(5):411-9. PubMed ID: 15239390
[TBL] [Abstract][Full Text] [Related]
53. Chronic myelogenous leukemia.
Mauro MJ; Druker BJ
Curr Opin Oncol; 2001 Jan; 13(1):3-7. PubMed ID: 11148678
[TBL] [Abstract][Full Text] [Related]
54. U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.
Cohen MH; Johnson JR; Pazdur R
Clin Cancer Res; 2005 Jan; 11(1):12-9. PubMed ID: 15671523
[TBL] [Abstract][Full Text] [Related]
55. [A new drug in the therapy of chronic myeloid leukemia: ST1571].
Salesi N; Bossone G; Della Longa G; Di Cocco B
Minerva Med; 2003 Apr; 94(2):71-6. PubMed ID: 12858155
[TBL] [Abstract][Full Text] [Related]
56. Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase.
Guilhot F; Apperley J; Kim DW; Bullorsky EO; Baccarani M; Roboz GJ; Amadori S; de Souza CA; Lipton JH; Hochhaus A; Heim D; Larson RA; Branford S; Muller MC; Agarwal P; Gollerkeri A; Talpaz M
Blood; 2007 May; 109(10):4143-50. PubMed ID: 17264298
[TBL] [Abstract][Full Text] [Related]
57. Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report.
Altintas A; Cil T; Kilinc I; Kaplan MA; Ayyildiz O
J Neurooncol; 2007 Aug; 84(1):103-5. PubMed ID: 17318411
[TBL] [Abstract][Full Text] [Related]
58. Hematologic and cytogenetic findings in eleven chronic myelogenous leukemia patients treated with imatinib mesylate at a tertiary care hospital.
Usman M; Kakepoto GN; Adil SN; Sajid R; Arain S; Khurshid M
J Pak Med Assoc; 2004 Jan; 54(1):17-20. PubMed ID: 15058636
[TBL] [Abstract][Full Text] [Related]
59. Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.
Terre C; Eclache V; Rousselot P; Imbert M; Charrin C; Gervais C; Mozziconacci MJ; Maarek O; Mossafa H; Auger N; Dastugue N; Talmant P; Van den Akker J; Leonard C; N'Guyen Khac F; Mugneret F; ViguiƩ F; Lafage-Pochitaloff M; Bastie JN; Roux GL; Nicolini F; Maloisel F; Vey N; Laurent G; Recher C; Vigier M; Yacouben Y; Giraudier S; Vernant JP; Salles B; Roussi J; Castaigne S; Leymarie V; Flandrin G; Lessard M;
Leukemia; 2004 Aug; 18(8):1340-6. PubMed ID: 15190256
[TBL] [Abstract][Full Text] [Related]
60. Chromosomal abnormalities in chronic myeloid leukemia: evidence of a hierarchy in imatinib treated cells.
Ostro D; Cheung K; Kamel-Reid S; Lipton JH
Leuk Lymphoma; 2007 May; 48(5):1029-31. PubMed ID: 17487749
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]